|
Arm/site/triplet
|
Baseline HIV prevalence
|
HIV incidence*
|
Stability/instability
|
Responsiveness/resistance
|
|---|
|
ARM A
|
|
Z2
|
Triplet 1
|
16.30% (14.2, 18.7)
|
1.64 (1.09, 2.38)
|
Mixed
|
Resistant
|
|
Z5
|
Triplet 2
|
17.40% (15.8, 19.2)
|
1.57 (1.08, 2.2)
|
Unstable
|
Mixed
|
|
Z8
|
Triplet 3
|
18.30% (16.5, 20.3)
|
1.36 (0.86, 2.04)
|
Stable
|
Resistant
|
|
Z10
|
Triplet 4
|
25.90% (23.9, 28)
|
1.93 (1.39, 2.62)
|
Unstable
|
Resistant
|
|
S14
|
Triplet 5
|
29.90% (28, 31.9)
|
2.36 (1.65, 3.27)
|
Mixed
|
Resistant
|
|
S16
|
Triplet 6
|
24.90% (23.1, 26.9)
|
1.43 (0.93, 2.1)
|
Unstable
|
Resistant
|
|
S19
|
Triplet 7
|
10.8%
|
0.5%
|
Unstable
|
Resistant
|
|
ARM B
|
|
Z1
|
Triplet 1
|
17.0% (14.7, 19.4)
|
0.94 (0.57, 1.48)
|
Stable
|
Responsive
|
|
Z6
|
Triplet 2
|
23.4% (21.7, 25.1)
|
1.2 (0.8, 1.72)
|
Stable
|
Mixed
|
|
Z9
|
Triplet 3
|
21.5% (19.4, 23.7)
|
1.3 (0.81, 1.97)
|
Mixed
|
Mixed
|
|
Z11
|
Triplet 4
|
24.2% (22.1, 26.4)
|
1.13 (0.68, 1.76)
|
Mixed
|
Mixed
|
|
SA13
|
Triplet 5
|
29.2% (27.4, 31.1)
|
1.8 (1.24, 2.53)
|
Mixed
|
Resistant
|
|
SA18
|
Triplet 6
|
19.9% (18.3, 21.5)
|
1.24 (0.81, 1.82)
|
Mixed
|
Responsive
|
|
SA20
|
Triplet 7
|
9.9% (8.7, 11.3)
|
0.4 (0.19, 0.74)
|
Stable
|
Responsive
|
|
ARM C
|
|
Z3
|
Triplet 1
|
21.9% (20, 23.9)
|
1.17 (0.75, 1.74)
|
Stable
|
Mixed
|
|
Z4
|
Triplet 2
|
18.1% (16.4, 20)
|
1.48 (1.02, 2.07)
|
Stable
|
Responsive
|
|
Z7
|
Triplet 3
|
19.6% (18, 21.4)
|
1.63 (1.1, 2.33)
|
Mixed
|
Resistant
|
|
Z12
|
Triplet 4
|
28.1% (25.5, 30.9)
|
2.39 (1.69, 3.29)
|
Unstable
|
Mixed
|
|
SA15
|
Triplet 5
|
28.0% (26, 30.1)
|
2.15 (1.43, 3.1)
|
Mixed
|
Resistant
|
|
SA17
|
Triplet 6
|
35.7% (33.6, 37.8)
|
2.31 (1.58, 3.27)
|
Unstable
|
Resistant
|
|
SA21
|
Triplet 7
|
3.0% (2.2, 4)
|
0.65 (0.36, 1.09)
|
Stable
|
Resistant
|
- *HIV incidence confidence intervals were wide since incidence estimates for individual communities were based on small numbers of events
